{"news_desk": "National", "print_page": "1", "section_name": "Health", "subsection_name": null, "byline": {"original": "By GINA KOLATA", "person": [{"rank": 1, "role": "reported", "firstname": "Gina", "organization": "", "lastname": "KOLATA"}]}, "abstract": "Two newly-approved cholesterol-lowering drugs, Praluent and Repatha, may offer solution for patients who fear side effects of commonly prescribed statins; cost of drugs, over $14,000 per year, adds to quandary for doctors, who must consider full impact on patients' lives of lifelong medicines they prescribe (Series: Mending Hearts). ", "type_of_material": "News", "word_count": "1469", "lead_paragraph": "Doctors find it difficult to ignore patients\u2019 complaints about statins, which are much cheaper, even though clinical trials have found that they have minimal side effects.", "pub_date": "2015-08-30T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "New Alternatives to Statins Add to a Quandary on Cholesterol", "content_kicker": "Mending Hearts", "print_headline": "New Drugs Add to a Quandary on Cholesterol", "kicker": "Mending Hearts"}, "snippet": "Doctors find it difficult to ignore patients\u2019 complaints about statins, which are much cheaper, even though clinical trials have found that they have minimal side effects.", "multimedia": [{"height": 126, "url": "images/2015/08/30/us/30statin-JP/30statin-JP-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/08/30/us/30statin-JP/30statin-JP-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/08/30/us/30statin-JP/30statin-JP-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/08/30/us/30statin-JP/30statin-JP-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/08/30/us/30statin-JP/30statin-JP-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/08/30/us/30statin-JP/30statin-JP-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/08/30/health/new-alternatives-to-statins-add-to-a-quandary-on-cholesterol.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Series", "name": "subject"}, {"rank": "11", "is_major": "N", "value": "Doctors", "name": "subject"}, {"rank": "12", "is_major": "N", "value": "Health Insurance and Managed Care", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Praluent (Drug)", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Repatha (Drug)", "name": "subject"}, {"rank": "4", "is_major": "Y", "value": "Statins (Cholesterol-Lowering Drugs)", "name": "subject"}, {"rank": "5", "is_major": "Y", "value": "Cholesterol", "name": "subject"}, {"rank": "6", "is_major": "Y", "value": "Heart", "name": "subject"}, {"rank": "7", "is_major": "N", "value": "Medicine and Health", "name": "subject"}, {"rank": "8", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "9", "is_major": "N", "value": "Clinical Trials", "name": "subject"}, {"rank": "10", "is_major": "N", "value": "Diabetes", "name": "subject"}], "blog": [], "_id": "55e221d838f0d84a4ed15427", "source": "The New York Times"}